Abbott introduces innovative glucose monitoring solutions for consumers and diabetics

Introduction

Abbott has recently obtained clearance from the U.S. FDA for two groundbreaking over-the-counter continuous glucose monitoring (CGM) systems: Lingo™ and Libre Rio™. These new devices are part of Abbott's leading FreeStyle Libre® technology.

Why CGM Technology Matters

Continuous glucose monitoring offers a comprehensive way to track glucose levels around the clock. This technology helps identify trends and patterns that a typical blood glucose meter might miss. By using a small sensor that transmits data to a smartphone app, users gain valuable insights into how diet, exercise, and stress influence their glucose levels.

Meet Lingo™

Lingo™ is designed for people above 18 who aim to improve their metabolic health rather than treat diabetes. It provides personalized insights such as tracking glucose levels and offering customized coaching. This can help users form healthier habits and understand how their body reacts to different stimuli.

Most Americans could improve their metabolism, with a University of North Carolina study indicating only 12% are metabolically healthy. Another survey revealed that 82% of Americans were willing to change their habits if provided with personalized coaching.

How Does Lingo™ Work?

The Lingo™ system uses a biosensor applied to the upper arm, which continuously streams glucose data for 14 days. This data is then analyzed by a smartphone app to offer recommendations on diet, exercise, and stress management.

Healthcare experts support the widespread use of continuous glucose monitors to improve general wellness and prevent long-term health issues like heart disease and diabetes.

Introducing Libre Rio™

Libre Rio™ offers a user-friendly option for people aged 18 and older with Type 2 diabetes not on insulin. It is Abbott's first over-the-counter CGM system in the U.S., providing a range of glucose measurements from 40-400 mg/dL. With fewer barriers to access, this system may enable better diabetes management and improve health outcomes.

Impact of FreeStyle Libre Systems

Freestyle Libre systems have revolutionized diabetes care globally, and millions of users have experienced improved glucose control and reduced healthcare utilization. By expanding access through over-the-counter systems, Abbott continues to innovate for people with diabetes.

Broader Access and Innovation

Abbott is committed to advancing healthcare by investing in new technologies and expanding its manufacturing capabilities. The company is also working on a first-of-its-kind sensor that can measure both glucose and ketone levels, demonstrating their long-term commitment to improving diabetes management.

About Abbott

Abbott is a global healthcare leader with diverse offerings in diagnostics, medical devices, nutritionals, and branded generic medicines. The company aims to help individuals live better lives at every stage of life through innovative health technologies.

Where to Learn More

For more information about Lingo™, visit their official website. Also, stay tuned for updates on future innovations from Abbott that aim to simplify and improve healthcare for people worldwide.